Revolutionizing ALS Treatment: BrainStorm’s Phase 3b Trial Moves Forward with FDA Approval Read More »
Revolutionizing Diabetes Treatment: Dr. Yoshihara’s $3 Million Journey into Stem Cell Therapy Read More »
